Differential sensitivities of bladder cancer cell lines to resveratol are unrelated to its metabolic profile

This publication has 74 references indexed in Scilit:

• Epigenetic mechanisms in anti‐cancer actions of bioactive food components – the implications in cancer prevention
  British Journal of Pharmacology, 2012
• Metabolic Patterns and Biotransformation Activities of Resveratrol in Human Glioblastoma Cells: Relevance with Therapeutic Efficacies
  PLOS ONE, 2011
• Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor Axis
  Cancer Research, 2010
• Clinical Pharmacology of Resveratrol and Its Metabolites in Colorectal Cancer Patients
  Cancer Research, 2010
• Induction of a reversible, non‐cytotoxic S‐phase delay by resveratrol: implications for a mechanism of lifespan prolongation and cancer protection
  British Journal of Pharmacology, 2009
• Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes
  Nature, 2007
• Structural and Chemical Profiling of the Human Cytosolic Sulfotransferases
  PLOS Biology, 2007
• Resveratrol improves health and survival of mice on a high-calorie diet
  Nature, 2006
• Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
  Nature, 2003
• The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1
  British Journal of Cancer, 2002